Preparation and biomedical applications of artificial cells
- PMID: 38075249
- PMCID: PMC10701372
- DOI: 10.1016/j.mtbio.2023.100877
Preparation and biomedical applications of artificial cells
Abstract
Artificial cells have received much attention in recent years as cell mimics with typical biological functions that can be adapted for therapeutic and diagnostic applications, as well as having an unlimited supply. Although remarkable progress has been made to construct complex multifunctional artificial cells, there are still significant differences between artificial cells and natural cells. It is therefore important to understand the techniques and challenges for the fabrication of artificial cells and their applications for further technological advancement. The key concepts of top-down and bottom-up methods for preparing artificial cells are summarized, and the advantages and disadvantages of the bottom-up methods are compared and critically discussed in this review. Potential applications of artificial cells as drug carriers (microcapsules), as signaling regulators for coordinating cellular communication and as bioreactors for biomolecule fabrication, are further discussed. The challenges and future trends for the development of artificial cells simulating the real activities of natural cells are finally described.
Keywords: Artificial cells; Bioreactors; Bottom-up approach; Cellular communication; Microcapsules.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Xu X., Jiang W., Chen L., Xu Z., Zhang Q., Zhu M., Ye P., Li H., Yu L., Zhou X., Zhou C., Chen X., Zheng X., Xu K., Cai H., Zheng S., Jiang W., Wu X., Li D., Chen L., Luo Q., Wang Y., Qu J., Li Y., Zheng W., Jiang Y., Tang L., Xiang C., Li L. Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: an exploratory clinical trial. Clin. Transl. Med. 2021;11:e297. - PMC - PubMed
-
- Chang T.M.S. 1957. Report on “Method for Preparing Artificial Hemoglobin Corpuscles”.
Publication types
LinkOut - more resources
Full Text Sources
